Abbreviations used: SSRI, selective serotonin reuptake inhibitor; 5-HT, serotonin; NE, 20 norepinephrine; ERK, extracellular signal-regulated kinase. 
Treatment with selective serotonin reuptake inhibitors (SSRIs) benefits many patients with 3 major depression disorders. However, current antidepressant therapies need a sustained 4 treatment of 2-4 weeks to be effective. In this regard, adaptive changes in both serotonergic 5 and noradrenergic neurotransmission, through the activation of the different serotonin (5-HT) 6 and norepinephrine (NE) receptor subtypes are believed to underlie the therapeutic efficacy of Castro et al. 2008 ). However, despite numerous studies available in the literature, the role of 13 the different neurotransmitter receptors in the mediation of the antidepressant effects of these 14 drugs has not been clearly established. Moreover, except for 5-HT 1A and 5-HT 2 receptors, few 15 data are available on the effect of chronic antidepressants administration on the other 5-HT 16 receptor subtypes. 17 The actions of 5-HT are mediated by at least 14 receptor subtypes (Hoyer et al. 2002; Barnes 18 and Sharp 1999) and their regulation by antidepressants is not yet fully understood. The 5- 19 HT 4 receptor exhibits a wide distribution throughout the central nervous system. In the brain, 20 this receptor is located postsynaptically primarly in the limbic areas (olfactory tubercule, 21 prefrontal cortex, hippocampus and amygdala) and basal ganglia (caudate-putamen and Andrade and Chaput 1991) . In addition to adenylate cyclase stimulation, a direct 2 coupling to both voltage-sensitive calcium channels (Hoyer et al. 2002) and extracellular 3 signal-regulated kinase (ERK) pathway (Barthet et al. 2007 ) has also been proposed. 4 Neurochemical and behavioural studies indicate that 5-HT 4 receptor agonists show antidepressant-like effects in some acute and chronic animal models of 16 depression (Lucas et al. 2007 ). Nevertheless, the information about modulation of 5-HT 4 
17
receptors by antidepressants is still very limited. 18 In keeping with these observations it is not unlikely that some adaptive changes in 5-HT 4 
19
receptors following chronic antidepressants drugs may occur. In the present study we have 20 aimed to evaluate the effect of chronic treatment with the SSRIs fluoxetine at three different 21 levels of 5-HT 4 receptor function (receptor number, regulation of adenylate cyclase activity 22 and receptor functionality in rat brain). Germany) using γ-globulin as the standard. (Table 1 and figure 1A ) whereas medial prefrontal cortex exhibited moderate densities 13 of this receptor as previously reported (Vilaró et al. 1996) . In rats treated with 10 mg/kg of 14 fluoxetine a significant decrease in the density of specific assayed, although a tendency to the decrease was observed (Table 1) . population spike assays, is around 1-2 µM. Although this potency is lower than that reported 15 in binding assays (Wong et al. 1996) , it is noteworthy that it is quite similar to the one 16 previously reported in studies analyzing the excitatory action of zacopride on population other receptor subtypes following chronic antidepressants could be involved in the regulation 10 of basal cAMP levels. 11 We have found that repeated treatment with fluoxetine causes a dose-dependent decrease in may be complex, but is conceivable to involve increased levels of extracellular 5-HT. 23 Nevertheless, it has been reported that forskolin, a direct activator of cAMP, also produce an 24 increase in population spike and this effect is decreased after the administration of the systems also taking place in hippocampus. Nevertheless, it is necessary to remark that caution 7 is needed when extrapolating data from the striatum to the hippocampus, since different 8 adenylate cyclase isoforms could be expressed depending on the brain area analyzed (see 9 Hanoune and Defer 2001). It is possible that the desensitization in zacopride-mediated 10 stimulation of population spike could be a direct consequence of the decrease in 5-HT 4 
11
receptor density in hippocampus. 12 Our results have to be also analyzed with regard to the recent report of an antidepressant agonists, involving activation of hippocampal plasticity (Lucas et al. 2007 ) strongly support 20 the relevance of our results.
21
In conclusion, the results of this study indicate that long-term fluoxetine administration 
